NASSI, Luca
 Distribuzione geografica
Continente #
EU - Europa 184
NA - Nord America 177
AS - Asia 88
SA - Sud America 16
AF - Africa 1
Totale 466
Nazione #
US - Stati Uniti d'America 167
IE - Irlanda 46
SG - Singapore 36
IT - Italia 33
DE - Germania 30
SE - Svezia 28
UA - Ucraina 17
IN - India 15
HK - Hong Kong 14
BR - Brasile 13
CN - Cina 13
RU - Federazione Russa 9
VN - Vietnam 7
CA - Canada 6
NL - Olanda 6
GB - Regno Unito 5
FR - Francia 3
ES - Italia 2
FI - Finlandia 2
MX - Messico 2
AR - Argentina 1
AT - Austria 1
BB - Barbados 1
CO - Colombia 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
IQ - Iraq 1
JP - Giappone 1
SR - Suriname 1
TC - Turks e Caicos 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 466
Città #
Dublin 46
Jacksonville 30
Singapore 18
Hong Kong 14
Piemonte 14
Ashburn 10
Wilmington 10
Dearborn 9
Beijing 7
Chandler 7
Los Angeles 7
Lawrence 6
Princeton 6
Buffalo 5
Dallas 5
Montreal 4
Munich 4
Phoenix 4
São Paulo 4
Taranto 4
Denver 3
Elmas 3
New York 3
Rimini 3
Amsterdam 2
Berlin 2
Bremen 2
Cassano Magnago 2
Changsha 2
Chicago 2
Frankfurt am Main 2
Grafing 2
Hanoi 2
Ho Chi Minh City 2
Menlo Park 2
Mexico City 2
Mumbai 2
Rome 2
San Mateo 2
Ankara 1
Ann Arbor 1
Atlanta 1
Augusta 1
Baghdad 1
Barranquilla 1
Bexley 1
Boardman 1
Boston 1
Brasília 1
Bridgetown 1
Campina Grande 1
Castanhal 1
Chennai 1
City of London 1
Columbus 1
Cristais Paulista 1
Cypress 1
East Chicago 1
Elloree 1
Enfield 1
Falkenstein 1
Houston 1
Jalandhar 1
Johannesburg 1
Juiz de Fora 1
Kunming 1
Milan 1
Monmouth Junction 1
Moscow 1
Ninh Bình 1
Novara 1
Nuremberg 1
Orem 1
Ottawa 1
Paramaribo 1
Pittsburgh 1
Poplar 1
Poços de Caldas 1
Prague 1
Providenciales 1
Recife 1
Roasio 1
Roubaix 1
Santa Clara 1
Santa Inês 1
Santa Rosa 1
Sopron 1
Stockholm 1
The Dalles 1
Tokyo 1
Tonawanda 1
Toronto 1
Torres 1
Turku 1
Vienna 1
Totale 312
Nome #
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi 79
Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score 79
Late relapse in patients with diffuse large B-cell lymphoma: impact of rituximab on their incidence and outcome 79
Circulating tumor DNA reveals genetics, clonal evolution and residual disease in classical Hodgkin lymphoma 72
Interferon-free compared to interferon-based antiviral regimens as first-line therapy for B-cell lymphoproliferative disorders associated with hepatitis C virus infection 68
Prognostic impact of TP53 mutation in newly diagnosed diffuse large B-cell lymphoma patients treated in the FIL-DLCL04 trial 61
null 37
Totale 475
Categoria #
all - tutte 2.793
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.793


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 1 5 7 5 4 5 0
2021/202239 0 2 0 9 3 0 2 0 2 1 9 11
2022/202391 6 5 11 0 6 6 5 1 47 0 2 2
2023/202436 2 2 4 2 5 0 4 0 0 2 9 6
2024/202575 1 5 6 2 3 0 1 12 14 5 4 22
2025/2026114 19 8 10 43 32 2 0 0 0 0 0 0
Totale 475